At present approximately 60,000 patients with chronic kidney disease are awaiting a kidney transplant but only 14,000 patients receive a graft each year due to a shortage of donor organs. Despite significant progress in the field of organ transplantation, loss of transplanted kidneys remains a major problem, largel. y due to accelerated vascular disease (""""""""transplant arteriosclerosis"""""""") as the result of vascular endothelial and smooth muscle cell proliferation. This is propagated by multiple factors including endothelial injury due to immune and non-immune processes, drug nephrotoxicity and hypertension and leads to progressive narrowing of the vascular lumen, ischemia, fibrosis and loss of kidney function. Given the extent of the problem, a molecular approach to inhibit vascular inflammation and neointimal proliferation would effectively ameliorate chronic vascular rejection and prolong graft survival, limiting the need for subsequent retransplantation or the return to dialysis. Our preliminary studies demonstrate a pivotal role for interleukin-10 (IL-10) in inhibiting vascular neointimal proliferation and inflammation in a rat model of chronic vascular rejection. The vascular protective effects of IL-10 are mediated via induction of heme oxygenase-1 (HO-1), an enzyme with recently recognized anti-inflammatory, anti-apoptotic and immunomodulatory functions. The overall hypothesis of this proposal is that IL-10 prevents chronic vascular rejection by inducing HO-1 expression inhibiting thereby neointimal proliferation and inflammation. To address this central hypothesis, four aims are proposed. The studies in Aim 1 will examine the role of HO-1 in mediating the effects of IL-10 on vascular neointimal proliferation and inflammation in aortic and kidney transplantation using HO-1-/- and HO-1+/+ recipient mice. The experiments in Aim 2 will determine the relative contribution of HO-1 expression in infiltrating hematopoietic cells versus locally in the graft vasculature in mediating the protective effects of IL- 10.
In Aim 3, the hematopoietic cell lineage required for the effects of IL-10 will be determined using adoptive transfer of specific cell populations from HO-1 and HO-1+/+ mice following aortic and kidney transplantation. Preclinical studies will be performed in Aim 4 to determine the link between IL-10 and HO-1 in an existing population of stable kidney allograft rhesus macaques that exhibit high levels of IL-10 and have no evidence of chronic vascular rejection. Lay Summary: Loss of kidney transplants due to progressive narrowing of blood vessels in the kidney is a significant clinical problem. The studies in this project will provide insights into potential novel therapies to prevent this condition and, hence, prolong survival of kidney transplants.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK075532-05
Application #
7822805
Study Section
Pathobiology of Kidney Disease Study Section (PBKD)
Program Officer
Flessner, Michael Francis
Project Start
2006-08-01
Project End
2011-05-31
Budget Start
2010-06-01
Budget End
2011-05-31
Support Year
5
Fiscal Year
2010
Total Cost
$280,994
Indirect Cost
Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Hull, Travis D; Bolisetty, Subhashini; DeAlmeida, Angela C et al. (2013) Heme oxygenase-1 expression protects the heart from acute injury caused by inducible Cre recombinase. Lab Invest 93:868-79
Zarjou, Abolfazl; Guo, Lingling; Sanders, Paul W et al. (2012) A reproducible mouse model of chronic allograft nephropathy with vasculopathy. Kidney Int 82:1231-5
Zarjou, Abolfazl; Sanders, Paul W; Mehta, Ravindra L et al. (2012) Enabling innovative translational research in acute kidney injury. Clin Transl Sci 5:93-101
Kim, Junghyun; Zarjou, Abolfazl; Traylor, Amie M et al. (2012) In vivo regulation of the heme oxygenase-1 gene in humanized transgenic mice. Kidney Int 82:278-91
Mannon, Roslyn B (2012) Macrophages: contributors to allograft dysfunction, repair, or innocent bystanders? Curr Opin Organ Transplant 17:20-5
Deshane, Jessy; Kim, Junghyun; Bolisetty, Subhashini et al. (2010) Sp1 regulates chromatin looping between an intronic enhancer and distal promoter of the human heme oxygenase-1 gene in renal cells. J Biol Chem 285:16476-86
Bolisetty, Subhashini; Traylor, Amie M; Kim, Junghyun et al. (2010) Heme oxygenase-1 inhibits renal tubular macroautophagy in acute kidney injury. J Am Soc Nephrol 21:1702-12
Wright, Marcienne M; Kim, Junghyun; Hock, Thomas D et al. (2009) Human haem oxygenase-1 induction by nitro-linoleic acid is mediated by cAMP, AP-1 and E-box response element interactions. Biochem J 422:353-61
Bolisetty, Subhashini; Agarwal, Anupam (2009) Neutrophils in acute kidney injury: not neutral any more. Kidney Int 75:674-6
Jarmi, Tambi; Agarwal, Anupam (2009) Heme oxygenase and renal disease. Curr Hypertens Rep 11:56-62

Showing the most recent 10 out of 17 publications